/KASE, June 17, 2026/ – The financial statements of Black Biotechnology LLP (KASE ticker: BKBT) for 2025 and the auditor's report have been published.

According to the report of SFAI Kazakhstan LLP, the financial statements reflect fairly, in all material respects, the financial position of Black Biotechnology LLP as of December 31, 2025, as well as its financial results and cash flows for the year ended on that date, in accordance with International Financial Reporting Standards (IFRS).

According to audited data as of December 31, 2025 (in thous. tenge, unless otherwise stated):

---------------------------------------------
                             as of     as of 
Indicator                  31.12.25  31.12.24
------------------------- --------- ---------
Authorized capital           60,100    60,100
Equity (capital deficit)   -308,957  -117,386
Total assets              2,281,047 2,359,270
Total liabilities         2,590,004 2,476,656
Revenue                     276,528   206,795
Gross profit (gross loss)   201,244   116,096
Net profit (net loss)      -261,659  -124,969
ROA, %                       -11.47     -5.30
ROE, %                        84.69    106.46
ROS, %                       -94.62    -60.43
---------------------------------------------

The financial statements and the report are published on – see more

[2026-06-17]